ST. LOUIS, Oct. 8 /PRNewswire-FirstCall/ -- Mass casualty incidents -- such as terrorist attacks, pandemic flu outbreaks or natural calamities like earthquakes or hurricanes -- raise the life-and-death reality that existing medical equipment is not adequate to provide treatment for all who need it. One of the most critical gaps is the lack of ventilators for people requiring respiratory support.

Disaster specialists and health care professionals know that mass casualty events could mean that:

-- skilled hospital personnel would be overwhelmed by the number of patients requiring mechanical ventilation;

-- mechanical ventilation for people with respiratory failure might have to be provided outside acute care hospitals, including in the field with caregivers, patients and care equipment exposed to the elements;

-- electrical power may not be available, possibly for several days or even longer.

A company in Missouri -- Allied Healthcare Products, Inc. -- has addressed these tough requirements by developing the first ventilator designed from inception to meet the unique demands of mass casualty incidents.

"Hospital ventilators are highly effective in the hands of skilled respiratory therapists. However, they also are very expensive, immobile, fragile and depend on a functioning power grid," said Earl Refsland, chief executive officer of Allied Healthcare. "In the event of a mass casualty event, we simply can not depend on hospital ventilators alone. That's why Allied decided to work on this solution."

With input from the medical community, disaster specialists and first responders, Allied designed the Mass Casualty Ventilator (MCV)100, a life-support device that is small, light weight, rugged, low-cost, easy to maintain and, importantly, easy to operate by non-specialists after simple instruction. The MCV100 recently received approval from the U.S. Food and Drug Administration (FDA).

"The MCV100 is a 'force m
'/>"/>

• AIDS/HIV
• Bioinformatics
• Biotechnology
• Biochemistry
• Cancer
• Cell Biology
• Developmental Biology
• Ecology
• Environment
• Evolution
• Food Technology
• Gene
• Genetics
• Genomics
• Health/Medicine
• Immunology
• Microarray
• Microbiology
• Molecular
• Marine Biology
• Nanobiotechnology
• Neurobiology
• Plant Sciences
• Stem Cell
• Systems Biology
• Virus
• Women Health

• Abortion
• Aches
• ADHD
• Addiction
• Alcohol
• Allergy
• Alternative Medicine
• Alzheimer's Dementia
• Anxiety/Stress
• Arthritis
• Autism
• Bacteria
• Blood
• Bird Flu/Avian Flu
• Bones
• Breast Cancer
• Cancer
• Cardiovascular
• Cervical Cancer
• Chikungunya
• Cholesterol
• Clinical Trials
• Colorectal Cancer
• Conferences
• Crohn's
• Cystic Fibrosis
• Dengue
• Dentistry
• Depression
• Diabetes
• Drug
• Eating Disorders
• Education
• Epilepsy
• Erectile Dysfunction
• Eye Health/Blindness
• Fertility
• Flu/Cold
• GastroIntestinal
• Genetics
• Gout
• Headache/Migraine
• Hearing/Deafness
• HIV/AIDS
• Huntington's Disease
• Hypertension
• Immune System/Vaccines
• Insurance
• Infectious Diseases
• Irritable-Bowel Syndrome
• Internet
• Leukemia
• Lifestyle
• Liver Disease/Hepatitis
• Lung Cancer
• Lupus
• Mad Cow Disease
• Medical Devices
• Medical Students/Training
• Medicare/Medicaid
• Medico
• Men's health
• Mental Health
• MRI/Ultrasound
• MRSA/Drug Resistance
• Multiple Sclerosis
• Muscular Dystrophy
• Neurology
• Nursing
• Nutrition/Diet
• Obesity/Weight Loss
• Pain/Anesthetics
• Parkinson's Disease
• Pediatrics/Children's Health
• Pharma/Biotech Industry
• Pharmacy/Pharmacists
• Pregnancy
• Premature
• Prostate
• Psychology/Psychiatry
• Rehabilitation
• Respiratory/Asthma
• SARS
• Schizophrenia
• Seniors/Aging
• Sexual Health
• Sleep/Sleep Disorders
• Smoking
• Statins
• Stem Cell Research
• Stroke
• Surgery
• Transplants/Organ Donations
• Viruses
• Water - Air Quality
• Women's Health